Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
Historic Wins: Last Severe Restrictions on Direct Access Eliminated

May 24, 2024/News

Recent changes in Alabama mean that all states now have either provisional or unrestricted access to physical therapy without a referral.

Incontinence Impact Questionnaire (IIQ)

Jan 6, 2014/Test & Measure

Measures effect of symptoms on quality of life and participation.

Wheelchair User’s Shoulder Pain Index (WUSPI)

Oct 28, 2014/Test & Measure

The WUSPI is a self-report measure of shoulder pain experienced during functional activities.

Passive Head-Shaking Nystagmus Test (pHSN)

Jun 7, 2017/Test & Measure

Assesses for latent spontaneous vestibular nystagmus through rapid, passive, head shaking around a vertical axis for the detection of vestibulopathies in dizzy patients.

Well to Do

Aug 1, 2017/Column

Well to Do: Wishing Doesn’t Make It So

Update to CMS Payment Calculations Further Eases Impact of Cut

Jan 6, 2021/News

The new conversion factor released by CMS helps to offset the impact of fee schedule reductions for PT providers.

APTA President's Podcast: Making Our Profession Sustainable Through Advocacy — The Work Never Stops

May 4, 2022/Podcast

Explore lesser-known APTA advocacy with President Roger Herr.

Gross Motor Function Measure (GMFM) - Down Syndrome (DS)

Jan 29, 2014/Test & Measure

Gross Motor Function Measure (GMFM) - Down Syndrome (DS)

Osteoporosis Self-Assessment Tool (OST)

Aug 9, 2017/Test & Measure

Used as a predictive tool to estimate the need for bone mineral density scans.

ACC / AHA / AACVPR / APMA / ABC / SCAI / SVM / SVN / SVS / SIR / VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on CPGs

May 11, 2024/CPG

Lower extremity peripheral artery disease is a common cardiovascular disease that is associated with significant morbidity, mortality and quality of life impairment. This collaborative guideline is an update of the 2016 guideline and provides new evidence to guide clinicians. Recommendation # 6 specifically